Regulatory T cells (Tregs) are now among the most intensively studied of T cell subsets and among the major targets of immune drug development because of their fundamental role in immune tolerance. The three papers featured as Pillars of Immunology in this issue of The Journal of Immunology were
No takes yet. Share an insight, caveat, or question.
Jeffrey A. Bluestone (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: